Matches in Wikidata for { <http://www.wikidata.org/entity/Q92373253> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q92373253 description "article scientifique publié en 2020" @default.
- Q92373253 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92373253 description "scientific article published on 02 January 2020" @default.
- Q92373253 description "wetenschappelijk artikel" @default.
- Q92373253 description "наукова стаття, опублікована 2 січня 2020" @default.
- Q92373253 name "Use of Epidermal Growth Factor Receptor Inhibitor Erlotinib to Treat Palmoplantar Keratoderma in Patients With Olmsted Syndrome Caused by TRPV3 Mutations" @default.
- Q92373253 name "Use of Epidermal Growth Factor Receptor Inhibitor Erlotinib to Treat Palmoplantar Keratoderma in Patients With Olmsted Syndrome Caused by TRPV3 Mutations" @default.
- Q92373253 type Item @default.
- Q92373253 label "Use of Epidermal Growth Factor Receptor Inhibitor Erlotinib to Treat Palmoplantar Keratoderma in Patients With Olmsted Syndrome Caused by TRPV3 Mutations" @default.
- Q92373253 label "Use of Epidermal Growth Factor Receptor Inhibitor Erlotinib to Treat Palmoplantar Keratoderma in Patients With Olmsted Syndrome Caused by TRPV3 Mutations" @default.
- Q92373253 prefLabel "Use of Epidermal Growth Factor Receptor Inhibitor Erlotinib to Treat Palmoplantar Keratoderma in Patients With Olmsted Syndrome Caused by TRPV3 Mutations" @default.
- Q92373253 prefLabel "Use of Epidermal Growth Factor Receptor Inhibitor Erlotinib to Treat Palmoplantar Keratoderma in Patients With Olmsted Syndrome Caused by TRPV3 Mutations" @default.
- Q92373253 P1433 Q92373253-64FA852E-E55F-44C6-B8BC-60139452BB0B @default.
- Q92373253 P1476 Q92373253-7A9A9EE8-C1E2-4222-A80B-45AD881D4F53 @default.
- Q92373253 P2093 Q92373253-1EE5A579-09D5-49FF-B696-37D02B89A347 @default.
- Q92373253 P2093 Q92373253-2F53AC4C-3695-4C81-9F8E-A9BFACA0E780 @default.
- Q92373253 P2093 Q92373253-58038CB3-1BD0-4942-BE1B-A7704BE81E91 @default.
- Q92373253 P2093 Q92373253-96783184-FB50-4CD4-BB80-20311331E9F2 @default.
- Q92373253 P2093 Q92373253-A59503EA-3DC0-4917-A639-ED212F7BFC1C @default.
- Q92373253 P2093 Q92373253-CE5F26CC-8B9B-4F57-961D-DCB53430A1FC @default.
- Q92373253 P2093 Q92373253-EEB38263-7697-41A5-A282-4D809A89DCBF @default.
- Q92373253 P2093 Q92373253-EF619063-1BC6-4FBE-B561-9ED2CA90234D @default.
- Q92373253 P31 Q92373253-5AB047A8-8F29-4E17-99AE-8475644DAE56 @default.
- Q92373253 P356 Q92373253-2CC98CB7-3E96-4769-95B8-BF2F07C5F2D8 @default.
- Q92373253 P577 Q92373253-C5FD3464-B04D-400B-A116-A65859B0B650 @default.
- Q92373253 P698 Q92373253-4EA4D7B4-EEB2-41E3-BF8E-B1D7DC0F69AA @default.
- Q92373253 P921 Q92373253-745149CE-A0F1-4F05-96C9-2BF0703821DE @default.
- Q92373253 P356 JAMADERMATOL.2019.4126 @default.
- Q92373253 P698 31895432 @default.
- Q92373253 P1433 Q3918707 @default.
- Q92373253 P1476 "Use of Epidermal Growth Factor Receptor Inhibitor Erlotinib to Treat Palmoplantar Keratoderma in Patients With Olmsted Syndrome Caused by TRPV3 Mutations" @default.
- Q92373253 P2093 "Christine Bodemer" @default.
- Q92373253 P2093 "Claude Boucheix" @default.
- Q92373253 P2093 "Céline Greco" @default.
- Q92373253 P2093 "François Doz" @default.
- Q92373253 P2093 "Sarah Chaumon" @default.
- Q92373253 P2093 "Smail Hadj-Rabia" @default.
- Q92373253 P2093 "Stéphanie Leclerc-Mercier" @default.
- Q92373253 P2093 "Thierry Molina" @default.
- Q92373253 P31 Q13442814 @default.
- Q92373253 P356 "10.1001/JAMADERMATOL.2019.4126" @default.
- Q92373253 P577 "2020-01-02T00:00:00Z" @default.
- Q92373253 P698 "31895432" @default.
- Q92373253 P921 Q7088441 @default.